Related Experiment Videos
Increased plasma granulocyte elastase levels in Behçet's disease
K Tsutsui1, M Hasegawa, M Takata
1Department of Dermatology, Kanazawa University School of Medicine, Japan.
The Journal of Rheumatology
|March 7, 1998
Summary
Elevated granulocyte elastase-alpha1-proteinase inhibitor (E-PI) complex levels are linked to thromboembolic vasculopathy in Behçet
Area of Science:
- Biochemistry
- Hematology
- Immunology
Background:
- Behçet's disease (BD) is a complex inflammatory disorder.
- Thromboembolic events are a significant complication in BD patients.
Purpose of the Study:
- To investigate the role of granulocyte elastase in the pathogenesis of thromboembolic vasculopathy in BD.
- To assess plasma E-PI complex levels as a potential biomarker for this complication.
Main Methods:
- Plasma E-PI complex levels were quantified using ELISA in BD patients and healthy controls.
- Deep vein thrombosis was assessed via venography.
- Hemostatic variables were concurrently measured.
Main Results:
- Significantly higher plasma E-PI complex levels were observed in BD patients with deep vein thrombosis compared to those without.
- BD patients without deep vein thrombosis also showed elevated E-PI levels compared to controls.
- Plasma E-PI levels correlated positively with serum plasmin-alpha2-plasmin inhibitor complex levels.
Conclusions:
- Plasma E-PI complex levels may serve as a valuable indicator for identifying thromboembolic vasculopathy in Behçet's disease.
- This finding highlights the potential involvement of neutrophil-derived proteases in BD-associated thrombosis.